Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohor...

Full description

Bibliographic Details
Main Authors: Mariangela Allocca, María Chaparro, Haidee Aleman Gonzalez, Marta Maia Bosca-Watts, Carolina Palmela, Ferdinando D’Amico, Eirini Zacharopoulou, Uri Kopylov, Pierre Ellul, Giorgos Bamias, Vassilios Ntelis, Adi Lahat, Gerassimos J Mantzaris, Ioannis Papaconstantinou, Konstantinos Katsanos, Yulia Uspenskaya, Dimitrios Christodoulou, Shomron Ben Horin, Laurent Peyrin-Biroulet, Joanna Torres, Shaji Sebastian, Javier P Gisbert, Silvio Danese, Gionata Fiorino
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
inflammatory bowel disease
immunosuppression
COVID-19
drugs
Online Access:https://www.mdpi.com/2077-0383/9/11/3533

Internet

https://www.mdpi.com/2077-0383/9/11/3533

Similar Items